Yet, the expression of SLC1A1, encoding EAAT3, has been found to be impaired in neuroinflammation-related diseases, such as multiple sclerosis, schizophrenia, hypoxia/ischemia, and epilepsy [42]. This evidence concerns the gene SLC1A1 and glycogen storage disease VI.